...
IMMXImmix Biopharma, Inc.
$4.71
Financials
NEUTRAL
Analysis updated: Jan 16, 2026

Investment Thesis

IMMX is neither a clear buy nor avoid. RS 92/99, moderate earnings. keep it on your radar.

Mixed signals = No edge currently

Key Takeaways

Earnings Momentum

+35%
Q4'24
$-0.17
+32%
Q1'25
$-0.15
-47%
Q2'25
$-0.22
N/A
Q3'25
$-0.24
Earnings Growing

Price Structure

Partial Alignment
Price
$4.71
→
50 DMA
$4.85
✓
→
100 DMA
$3.68
✓
→
150 DMA
$3.29
✓
→
200 DMA
$2.96
Alignment Score: 3/4

IMMX Price Chart

Loading chart...

50 DMA150 DMA200 DMA

Why Not BUY Yet?

EPS Growth
0%→>25% (Strong) or 40%+ (Elite)
Pattern
No base forming→VCP or constructive base
Entry Point
Broke out 2mo ago, now +37%→Wait for pullback or new base

What Would Change Our Mind?

To turn bullish on IMMX, we need:

Twin Engines Dashboard

Technical Health

RS Rating
92/99
Top 8% ✓
Trend
Uptrend
Above 200 DMA
RSI (14)
47
NEUTRAL
VCP Setup
COOL
Score: 3/9
Volume
673K
-38% vs avg
From Entry
+37.3%
$3.43

Fundamental Horsepower

EPS Qtr YoY
+0%
Declining
EPS 3Y CAGR
N/A
Annual Earnings
Revenue Qtr
N/A
NO DATA
F-Score
2/9
Piotroski Quality
ROE
-1%
Return on Equity
EPS Rank
50/99
Percentile

Trade Plan

Lost Momentum

Broke out 2 months ago at $3.43 — +37% from entry but below EMA support.

Lost momentum. Wait for price to reclaim $5.10 (21 EMA) or form a new base.

Breakout Date2025-10-2385 days ago
Entry Was$3.43Breakout price
Gain Since+37%From entry
Reclaim$5.1021 EMA support

If/Then Playbook

IF: RS Rating improves to >80
THEN: Re-evaluate for potential
IF: EPS growth accelerates next quarter
THEN: Check for developing setup
IF: VCP pattern begins forming
THEN: Add to watchlist if RS also improving
IF: Price breaks below 200 DMA
THEN: Remove from radar

Key Price Levels

Resistance

  • 50 DMA$4.85+3.0%
  • 20 DMA$5.25+11.5%
  • 52W High$7.73+64.1%
Current$4.71

Support

  • 200 DMA$2.96-37.2%
  • 52W Low$1.34-71.5%

More IMMX Analysis

Fundamental Analysis →Intrinsic Value →Total Return Calculator →

Related Technical Analysis

Compare technical setups for similar stocks:

Frequently Asked Questions

Is IMMX stock a buy now?

IMMX is neither a clear buy nor avoid. RS 92/99, moderate earnings. keep it on your radar.

What is the buy point for IMMX?

IMMX broke out at $3.43 2 month(s) ago and is now +37% extended. Wait for a pullback to the 21 EMA or a new base pattern.

What is IMMX's RS Rating?

IMMX has an RS Rating of 92/99, meaning it's in the Top 8% of all stocks for relative price performance over the past 12 months. Minervini recommends RS 80+ for momentum trades.

Important Disclosure: This analysis is for educational and informational purposes only. Technical and fundamental indicators are based on historical data and do not guarantee future performance. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.